SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 405 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,312,154 | -1.7% | 20,963 | -19.5% | 3.41% | +0.5% |
Q1 2024 | $3,369,585 | +79.5% | 26,028 | +33.7% | 3.39% | +63.6% |
Q4 2023 | $1,877,106 | -7.0% | 19,466 | +16.9% | 2.07% | -20.4% |
Q3 2023 | $2,018,313 | -11.2% | 16,650 | -16.1% | 2.60% | -4.8% |
Q2 2023 | $2,271,619 | -54.5% | 19,836 | -45.2% | 2.74% | -60.4% |
Q1 2023 | $4,988,068 | -39.6% | 36,190 | -43.2% | 6.91% | -12.9% |
Q4 2022 | $8,261,502 | +24.1% | 63,756 | +5.9% | 7.93% | +23.9% |
Q3 2022 | $6,658,000 | +76.8% | 60,231 | +19.9% | 6.40% | +56.2% |
Q2 2022 | $3,765,000 | -18.7% | 50,225 | -15.3% | 4.10% | +27.3% |
Q1 2022 | $4,632,000 | -46.8% | 59,299 | -38.7% | 3.22% | -23.0% |
Q4 2021 | $8,707,000 | +8.0% | 96,695 | +10.9% | 4.18% | +16.8% |
Q3 2021 | $8,065,000 | +32.5% | 87,213 | +11.3% | 3.58% | +27.5% |
Q2 2021 | $6,089,000 | +18.5% | 78,330 | +13.6% | 2.81% | -7.6% |
Q1 2021 | $5,138,000 | +1.6% | 68,937 | +132.3% | 3.04% | -21.2% |
Q4 2020 | $5,059,000 | – | 29,672 | – | 3.86% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |